Discovery on Target brings together the science, technology, and people driving the future of drug discovery. For more than 20 years, the meeting has showcased breakthroughs shaping therapeutic innovation across small molecules, antibodies, and emerging modalities—including peptides, conjugates, and radiopharmaceuticals.

Across four days and seven concurrent tracks, 1,000+ attendees explore advances in target discovery, lead generation, screening technologies, AI/ML, and next-generation biologics—while connecting through presentations, exhibits, posters, and interactive sessions designed to spark collaboration and move discovery forward.